Efficacy and Safety of Regimens Used for the Treatment of POEMS Syndrome- A Systematic Review
POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy/edema, monoclonal plasma protein [M protein], and skin changes) is a rare paraneoplastic disorder associated with underlying plasma cell neoplasia. Although limited-stage disease can be treated with radiotherapy, treatment for the more advanced disease remains unclear. The most commonly used therapies for POEMS syndrome include alkylators and steroids, high-dose chemotherapy with autologous stem cell transplantation, lenalidomide, and bortezomib.
Source: Clinical Lymphoma, Myeloma and Leukemia - Category: Hematology Authors: Unaiza Faizan, Muhammad Khawar Sana, Muhammad Saad Farooqi, Hamza Hashmi Source Type: research
More News: Chemotherapy | Hematology | Leukemia | Lymphoma | Myeloma | Paraneoplastic Syndrome | Revlimid | Skin | Stem Cell Therapy | Stem Cells | Transplants | Velcade